Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1760 of 6351
-
AI could make colonoscopies easier for lynch syndrome patients
Disease control Recruiting nowLynch syndrome (LS) is the most common genetic predisposition syndrome for colorectal cancer (CRC), responsible for around 2-4% of cancers. It is characterized by a pathogenic germline mutation in one of the DNA mismatch repair genes (path\_MMR) MLH1, MSH2, MSH6, PMS2 or a deleti…
Sponsor: PERROD Guillaume • Aim: Disease control
Last updated Jun 26, 2026 12:33 UTC
-
New implant offers hope for sleep apnea patients who hate CPAP
Disease control Recruiting nowHypoglossal nerve stimulation (HNS) therapy (Inspire system) is intended for the treatment of patients with moderate to severe obstructive sleep apnea (OSA) who cannot be effectively treated with the first-line treatment options. Recently, the request for reimbursement of the Ins…
Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Jun 26, 2026 17:10 UTC
-
Experimental donor immune cells target Hard-to-Treat lymphoma
Disease control OngoingSC262-101 is a Phase 1 study to evaluate SC262 safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory biomarkers.
Phase 1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Personalized mRNA cancer vaccine trial halted midway
Disease control Stopped earlyThis is a two-part (Phase 2/Phase 3) study of intismeran autogene, an individualized neoantigen therapy (INT), plus pembrolizumab in participants with locally resectable advanced cutaneous squamous cell carcinoma (LA cSCC). Phase 2 has three arms intismeran autogene plus pembroli…
Phase 2/3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Double-Drug attack on Crohn's: could two biologics be better than one?
Disease control Recruiting nowThe main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alo…
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Smart insulin pump shows promise for diabetics with kidney failure
Disease control CompletedThe goal of this this randomized, clinical trial is to test an automated insulin delivery system (AID) in people with type 1 or type 2 diabetes who are on hemodialysis, peritoneal dialysis, or have advanced chronic kidney disease (CKD). The main objective is: • To test if the A…
Sponsor: Steno Diabetes Center Copenhagen • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could five doses of proton therapy before surgery improve sarcoma outcomes?
Disease control Recruiting nowThis study is being done to examine whether proton therapy for certain kinds of sarcomas (extremity and trunk soft tissue) is safe and effective. As part of the study, patients will have five fractions of proton therapy before the participants have surgery for the sarcoma. The st…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Retraining the brain: could a Thought-Focused app ease OCD?
Symptom relief CompletedThought-Action-Fusion (TAF) is a cognitive bias that posits (1) having unwanted thoughts is morally equivalent to acting upon the thoughts (TAF-Moral; e.g., "Thinking about harming a child is as immoral as actually harming a child") and (2) having unwanted thoughts will increase …
Sponsor: Han Joo Lee • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Sleep coaching may be the missing ingredient in teen weight loss
Disease control Recruiting nowThis study is being performed to understand the effects of a lifestyle modification and sleep intervention on weight loss outcomes in adolescence. The main question the study aims to answer is: \- What are the initial effects of a lifestyle modification and sleep intervention, i…
Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a 9-Week online course ease the wait for a kidney transplant?
Symptom relief CompletedThe goal of this study is to test the feasibility study of an internet based education and support program for patients awaiting kidney transplantation. The study is designed as a national pilot randomized controlled trial with a waitlist control group, to test the feasibility, a…
Sponsor: Linkoeping University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Micro-Coil stent aims to drain glaucoma pressure during cataract surgery
Disease control OngoingThe purpose of this research study is to evaluate the safety and effectiveness of the Aquea Intracanalicular Glaucoma Stent in lowering intraocular pressure (IOP) in patients with cataract and open angle glaucoma. The main questions it aims to answer are: * What proportion of e…
Sponsor: Aquea Health, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Glow stick for cancer: new dye helps surgeons spot hidden tumors
Diagnosis Recruiting nowThis is a non-randomized, open-label, single-center, safety and imaging feasibility study of Pegsitacianine, an intraoperative fluorescence imaging agent.
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Two quick breathing tests could spare ICU patients from failed ventilator removal
Knowledge-focused CompletedWeaning from invasive mechanical ventilation (IMV) is a critical stage of the intensive care unit (ICU) stay. Premature IMV discontinuation may expose patients to substantial cardiopulmonary stress, whereas prolonged weaning increases exposure to complications associated with IMV…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is researching whether the combination of Afatinib and Pemigatinib is safe and effective in FGFR altered unresectable or metastatic advanced solid tumors. The study is also trying to discover the highest doses of the study drugs that can be administered without causin…
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Spinal implant could ease diabetic nerve pain
Symptom relief Recruiting nowThis is a prospective randomized control trial. Participants enrolled into the study will be randomized into one of three groups, two of which are treatment groups and the third is a control group. A time course of measurements before and after spinal cord stimulation (SCS) treat…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New drug siplizumab tested in ALS patients – early trial begins
Disease control Stopped earlyThe purpose of this study is to investigate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of TCD601 (siplizumab) in newly diagnosed adult ALS patients.
Phase 1 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could MDMA help new moms battling PTSD and opioid addiction?
Disease control Recruiting nowThis is an open-label study of the use of MDMA Assisted Therapy for postpartum people with co-occurring Post Traumatic Stress Disorder (PTSD) and Opioid Use Disorder (OUD). The study protocol has been adapted from the Phase 3 studies sponsored by the Multidisciplinary Association…
Phase 2 • Sponsor: University of New Mexico • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New eye injection shows promise for restoring sight after stroke in the eye
Disease control CompletedCentral retinal artery occlusion (CRAO) is an ophthalmologic emergency which leads to severe and permanent vision loss. There is no evidence-based therapy for CRAO. The objective of this GION study is to evaluate the efficacy and safety of KUS121 intravitreal (IVT) injection in p…
Phase 2 • Sponsor: Kyoto Drug Discovery and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New MS drug tolebrutinib tested for Long-Term safety in 2,500 patients
Disease control OngoingThis is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥18 years) with RMS, PPMS, or NRSPMS who were previously enrolled in the Phase 2b LTS (LTS16004) or 1 of the 4 Phase 3 tolebrutinib p…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New antibody drug shows promise for Hard-to-Treat cancers
Disease control OngoingPhase I/II open label, multicenter study to evaluate the efficacy and safety of MHB039A in advanced malignant tumors.
Phase 1/2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC